An elevated level of miR-21 was shown to promote drug resistance to 5-FU and enhance the proliferation of pancreatic cancer cells by downregulating the expression of its target genes PTEN and PDCD4 [75]. This evidence concerns the gene PDCD4 and familial pancreatic carcinoma.